These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20713551)

  • 21. Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride.
    Chen YY; Li ZZ; Ye YY; Xu F; Niu RJ; Zhang HC; Zhang YJ; Liu YB; Han BS
    BMC Mol Biol; 2016 Mar; 17():6. PubMed ID: 26935744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].
    Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF
    Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z
    Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.
    Shi R; Li W; Zhang X; Zhang Y; Peng H; Xie Y; Fan D; Liu R; Liu X; Xiong D
    Eur J Pharmacol; 2011 Nov; 669(1-3):38-44. PubMed ID: 21871878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.
    Kim HB; Lee SH; Um JH; Kim MJ; Hyun SK; Gong EJ; Oh WK; Kang CD; Kim SH
    Int J Biol Sci; 2015; 11(8):923-34. PubMed ID: 26157347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extract of Bryophyllum laetivirens reverses etoposide resistance in human lung A549 cancer cells by downregulation of NF-κB.
    Kaewpiboon C; Srisuttee R; Malilas W; Moon J; Kaowinn S; Cho IR; Johnston RN; Assavalapsakul W; Chung YH
    Oncol Rep; 2014 Jan; 31(1):161-8. PubMed ID: 24220725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
    Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC
    Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cells.
    Xue P; Yang X; Liu Y; Xiong C; Ruan J
    Biomed Pharmacother; 2014 Oct; 68(8):1049-56. PubMed ID: 25455158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
    De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS
    Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amurensin G enhances the susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity of cancer stem-like cells of HCT-15 cells.
    Lee SH; Kim MJ; Kim DW; Kang CD; Kim SH
    Cancer Sci; 2013 Dec; 104(12):1632-9. PubMed ID: 24118446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells.
    Tsou SH; Hou MH; Hsu LC; Chen TM; Chen YH
    Int J Mol Med; 2016 Jan; 37(1):233-42. PubMed ID: 26572087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells.
    Li Y; Sun Y; Tang T; Niu Y; Li X; Xie M; Jin H; Mei Q
    J Ethnopharmacol; 2019 Mar; 232():47-54. PubMed ID: 30552993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo.
    Zhang P; Zheng BB; Wang HY; Chen JH; Liu XY; Guo XL
    J Pharm Pharmacol; 2014 Mar; 66(3):398-407. PubMed ID: 24533823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
    Tsou SH; Chen TM; Hsiao HT; Chen YH
    PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
    Park SJ; Wu CH; Safa AR
    Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.